Accelrys, Inc. · San Diego, CA United States ·(NASDAQ (GM): ACCL)

Accelrys knows nothing can accelerate research like good software. It develops scientific business intelligence software that clients use to accelerate the discovery and development of new drugs and technological discoveries. Its software and services are used to collect, aggregate, and analyze scientific data and include tools for reporting and collaboration. While its customers are primarily involved in the pharmaceutical, life sciences, and biotech industries, Accelrys also counts clients involved in industries with significant R&D efforts such as energy, aerospace, and consumer packaged goods; end users for its products are typically scientists, engineers, biologists, chemists, and IT staff. To read the full description, subscribe now.